Primordial Genetics received an I-Corps™ at NIH grant for $55K to conduct a detailed market survey on enzymatic DNA synthesis. These funds are designed to allow companies to do customer interviews so they can better define the needs of the market and aim their technology development to exactly match that need.
The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact.
